Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

2.

Function, information, and contributions: An evaluation of national multidisciplinary team meetings for rare cancers.

Rosell L, Wihl J, Hagberg O, Ohlsson B, Nilbert M.

Rare Tumors. 2019 May 8;11:2036361319841696. doi: 10.1177/2036361319841696. eCollection 2019.

3.

WITHDRAWAL-Administrative Duplicate Publication: The essential role of prevention in reducing the cancer burden in Europe: a commentary from Cancer Prevention Europe.

Espina C, Bauld L, Bonanni B, Brenner H, Brown K, Dillner J, Kampman E, Nilbert M, Vineis P, Weijenberg MP, Cox A, de Kok TM, Fecht D, Mitrou G, Muller DC, Serrano D, Steindorf K, Storm H, Thorat MA, van Duijnhoven F, Weiderpass E, Schüz J.

Tumori. 2019 May 17:300891619851865. doi: 10.1177/0300891619851865. [Epub ahead of print] No abstract available. Erratum in: Tumori. 2019 Aug 27;:300891619867815.

4.

Publishing your trial protocols with Acta Oncologica; your contribution to scientific transparency.

Nilbert M, Overgaard J.

Acta Oncol. 2019 Jun;58(6):821. doi: 10.1080/0284186X.2019.1614219. Epub 2019 May 11. No abstract available.

PMID:
31079524
5.

Rational targeting of population groups and residential areas for colorectal cancer screening.

Strömberg U, Peterson S, Holmén A, Holmberg E, Hultcrantz R, Martling A, Nilbert M.

Cancer Epidemiol. 2019 Jun;60:23-30. doi: 10.1016/j.canep.2019.01.009. Epub 2019 Mar 18.

PMID:
30897387
6.

A welcome from the new Editor-in-Chief.

Nilbert M.

Acta Oncol. 2019 Feb;58(2):133-134. doi: 10.1080/0284186X.2019.1566777. Epub 2019 Feb 6. No abstract available.

PMID:
30724691
7.

Cancer Prevention Europe.

Wild CP, Espina C, Bauld L, Bonanni B, Brenner H, Brown K, Dillner J, Forman D, Kampman E, Nilbert M, Steindorf K, Storm H, Vineis P, Baumann M, Schüz J.

Mol Oncol. 2019 Mar;13(3):528-534. doi: 10.1002/1878-0261.12455. Epub 2019 Feb 13. Review.

8.

Diagnostic spectrum and time intervals in Sweden's first diagnostic center for patients with nonspecific symptoms of cancer.

Stenman E, Palmér K, Rydén S, Sävblom C, Svensson I, Rose C, Ji J, Nilbert M, Sundquist J.

Acta Oncol. 2019 Mar;58(3):296-305. doi: 10.1080/0284186X.2018.1537506. Epub 2019 Jan 11.

PMID:
30632871
9.

Immunoprofiles of colorectal cancer from Lynch syndrome.

Walkowska J, Kallemose T, Jönsson G, Jönsson M, Andersen O, Andersen MH, Svane IM, Langkilde A, Nilbert M, Therkildsen C.

Oncoimmunology. 2018 Sep 26;8(1):e1515612. doi: 10.1080/2162402X.2018.1515612. eCollection 2019.

10.

Diagnostic pathway efficacy for urinary tract cancer: population-based outcome of standardized evaluation for macroscopic haematuria.

Nilbert M, Bläckberg M, Ceberg J, Hagberg O, Stenhoff R, Liedberg F.

Scand J Urol. 2018 Aug;52(4):237-243. doi: 10.1080/21681805.2018.1498124. Epub 2018 Nov 9.

PMID:
30411661
11.

Risk of multiple colorectal cancer development depends on age and subgroup in individuals with hereditary predisposition.

Lindberg LJ, Wegen-Haitsma W, Ladelund S, Smith-Hansen L, Therkildsen C, Bernstein I, Nilbert M.

Fam Cancer. 2019 Apr;18(2):183-191. doi: 10.1007/s10689-018-0109-z.

PMID:
30302651
12.

Risk of Synchronous and Metachronous Colorectal Cancer: Population-Based Estimates in Denmark with Focus on Non-Hereditary Cases Diagnosed After Age 50.

Lindberg LJ, Ladelund S, Bernstein I, Therkildsen C, Nilbert M.

Scand J Surg. 2019 Jun;108(2):152-158. doi: 10.1177/1457496918798212. Epub 2018 Sep 10.

PMID:
30196753
13.

Molecular subtype classification of urothelial carcinoma in Lynch syndrome.

Therkildsen C, Eriksson P, Höglund M, Jönsson M, Sjödahl G, Nilbert M, Liedberg F.

Mol Oncol. 2018 Aug;12(8):1286-1295. doi: 10.1002/1878-0261.12325. Epub 2018 Jun 19.

14.

Multiprofessionella team nyckel till ökad överlevnad vid Lynchs syndrom.

Liedberg F, Nilbert M.

Lakartidningen. 2018 May 17;115. pii: E7DS. Swedish. No abstract available.

PMID:
29786799
Free Article
15.

Unsolicited information letters to increase awareness of Lynch syndrome and familial colorectal cancer: reactions and attitudes.

Petersen HV, Frederiksen BL, Lautrup CK, Lindberg LJ, Ladelund S, Nilbert M.

Fam Cancer. 2019 Jan;18(1):43-51. doi: 10.1007/s10689-018-0083-5.

PMID:
29651783
16.

Benefits, barriers and opinions on multidisciplinary team meetings: a survey in Swedish cancer care.

Rosell L, Alexandersson N, Hagberg O, Nilbert M.

BMC Health Serv Res. 2018 Apr 5;18(1):249. doi: 10.1186/s12913-018-2990-4.

17.

Determinants of variable resource use for multidisciplinary team meetings in cancer care.

Alexandersson N, Rosell L, Wihl J, Ohlsson B, Steen Carlsson K, Nilbert M.

Acta Oncol. 2018 May;57(5):675-680. doi: 10.1080/0284186X.2017.1400682. Epub 2017 Dec 3.

PMID:
29199517
18.

Genetic anticipation in Swedish Lynch syndrome families.

von Salomé J, Boonstra PS, Karimi M, Silander G, Stenmark-Askmalm M, Gebre-Medhin S, Aravidis C, Nilbert M, Lindblom A, Lagerstedt-Robinson K.

PLoS Genet. 2017 Oct 31;13(10):e1007012. doi: 10.1371/journal.pgen.1007012. eCollection 2017 Oct.

19.

The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma.

Bertucci F, De Nonneville A, Finetti P, Perrot D, Nilbert M, Italiano A, Le Cesne A, Skubitz KM, Blay JY, Birnbaum D.

Ann Oncol. 2018 Feb 1;29(2):459-465. doi: 10.1093/annonc/mdx699.

PMID:
29069276
20.

Towards gene- and gender-based risk estimates in Lynch syndrome; age-specific incidences for 13 extra-colorectal cancer types.

Therkildsen C, Ladelund S, Smith-Hansen L, Lindberg LJ, Nilbert M.

Br J Cancer. 2017 Nov 21;117(11):1702-1710. doi: 10.1038/bjc.2017.348. Epub 2017 Oct 24.

21.

Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type X.

Haraldsson S, Klarskov L, Nilbert M, Bernstein I, Bonde J, Holck S.

BMC Clin Pathol. 2017 Aug 17;17:11. doi: 10.1186/s12907-017-0052-1. eCollection 2017.

22.

Involvement of Chromatin Remodeling Genes and the Rho GTPases RhoB and CDC42 in Ovarian Clear Cell Carcinoma.

Arildsen NS, Jönsson JM, Bartuma K, Ebbesson A, Westbom-Fremer S, Måsbäck A, Malander S, Nilbert M, Hedenfalk IA.

Front Oncol. 2017 May 29;7:109. doi: 10.3389/fonc.2017.00109. eCollection 2017.

23.

Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response.

Martín de la Fuente L, Malander S, Hartman L, Jönsson JM, Ebbesson A, Nilbert M, Måsbäck A, Hedenfalk I.

Int J Gynecol Pathol. 2018 Mar;37(2):101-109. doi: 10.1097/PGP.0000000000000394.

24.

Hypoxia-inducible factor 1α predicts recurrence in high-grade soft tissue sarcoma of extremities and trunk wall.

Nyström H, Jönsson M, Werner-Hartman L, Nilbert M, Carneiro A.

J Clin Pathol. 2017 Oct;70(10):879-885. doi: 10.1136/jclinpath-2016-204149. Epub 2017 Apr 12.

PMID:
28404817
25.

Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.

Lagerstedt-Robinson K, Rohlin A, Aravidis C, Melin B, Nordling M, Stenmark-Askmalm M, Lindblom A, Nilbert M.

Oncol Rep. 2016 Nov;36(5):2823-2835. doi: 10.3892/or.2016.5060. Epub 2016 Sep 1.

26.

Expanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testing.

Rohlin A, Rambech E, Kvist A, Törngren T, Eiengård F, Lundstam U, Zagoras T, Gebre-Medhin S, Borg Å, Björk J, Nilbert M, Nordling M.

Fam Cancer. 2017 Apr;16(2):195-203. doi: 10.1007/s10689-016-9934-0.

27.

Fast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective: results from a prospective intervention study.

Liedberg F, Gerdtham U, Gralén K, Gudjonsson S, Jahnson S, Johansson I, Hagberg O, Larsson S, Lind AK, Löfgren A, Wanegård J, Åberg H, Nilbert M.

Br J Cancer. 2016 Sep 27;115(7):770-5. doi: 10.1038/bjc.2016.265. Epub 2016 Aug 25.

28.

Socioeconomic inequalities in breast cancer incidence and mortality in Europe-a systematic review and meta-analysis.

Lundqvist A, Andersson E, Ahlberg I, Nilbert M, Gerdtham U.

Eur J Public Health. 2016 Oct;26(5):804-813. Epub 2016 May 23. Review.

29.

Renal cell cancer linked to Lynch syndrome: Increased incidence and loss of mismatch repair protein expression.

Therkildsen C, Joost P, Lindberg LJ, Ladelund S, Smith-Hansen L, Nilbert M.

Int J Urol. 2016 Jun;23(6):528-9. doi: 10.1111/iju.13094. Epub 2016 May 10. No abstract available.

30.

Frequent mismatch-repair defects link prostate cancer to Lynch syndrome.

Dominguez-Valentin M, Joost P, Therkildsen C, Jonsson M, Rambech E, Nilbert M.

BMC Urol. 2016 Mar 24;16:15. doi: 10.1186/s12894-016-0130-1.

31.

No evidence of increased breast cancer risk for proven noncarriers from BRCA1 and BRCA2 families.

Nielsen HR, Petersen J, Krogh L, Nilbert M, Skytte AB.

Fam Cancer. 2016 Oct;15(4):523-8. doi: 10.1007/s10689-016-9898-0.

PMID:
26951453
32.

Cutaneous malignant melanoma show geographic and socioeconomic disparities in stage at diagnosis and excess mortality.

Strömberg U, Peterson S, Holmberg E, Holmén A, Persson B, Sandberg C, Nilbert M.

Acta Oncol. 2016 Aug;55(8):993-1000. doi: 10.3109/0284186X.2016.1144934. Epub 2016 Mar 3.

PMID:
26935355
33.

BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population.

Nielsen HR, Nilbert M, Petersen J, Ladelund S, Thomassen M, Pedersen IS, Hansen TV, Skytte AB, Borg Å, Therkildsen C.

Fam Cancer. 2016 Oct;15(4):507-12. doi: 10.1007/s10689-016-9875-7.

PMID:
26833046
34.

Patient representatives' views on patient information in clinical cancer trials.

Dellson P, Nilbert M, Carlsson C.

BMC Health Serv Res. 2016 Feb 1;16:36. doi: 10.1186/s12913-016-1272-2.

35.

[Waiting times in cancer care is a patient safety issue].

Nilbert M.

Lakartidningen. 2016 Jan 6;113. pii: DRFY. Swedish.

36.

[Coordinated surgery--winning ticket for the patients].

Nordenström E, Rydén S, Roos H, Johnsson F, Wennerberg J, Greiff L, Linde M, Nilbert M.

Lakartidningen. 2015 Dec 15;112. pii: DT9S. Swedish. No abstract available.

37.

Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival.

Jönsson JM, Skovbjerg Arildsen N, Malander S, Måsbäck A, Hartman L, Nilbert M, Hedenfalk I.

Transl Oncol. 2015 Oct;8(5):424-33. doi: 10.1016/j.tranon.2015.09.002.

38.

Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations.

Joost P, Therkildsen C, Dominguez-Valentin M, Jönsson M, Nilbert M.

Urology. 2015 Dec;86(6):1212-7. doi: 10.1016/j.urology.2015.08.018. Epub 2015 Sep 15.

PMID:
26385421
39.

Increased risk of male cancer and identification of a potential prostate cancer cluster region in BRCA2.

Roed Nielsen H, Petersen J, Therkildsen C, Skytte AB, Nilbert M.

Acta Oncol. 2016;55(1):38-44. doi: 10.3109/0284186X.2015.1067714. Epub 2015 Sep 11.

PMID:
26360800
40.

[Regional cancer centers in collaboration: The time is ripe for open reporting within pathology].

Regionala cancercentrum i samverkan, Enoksson J, Gunnarsson G, Conradi N, Henriksson R, Holmberg L, Melin B, Nilbert M, Uppugunduri S.

Lakartidningen. 2015 May 11;112. pii: DHYH. Swedish. No abstract available.

41.

Glioblastomas, astrocytomas and oligodendrogliomas linked to Lynch syndrome.

Therkildsen C, Ladelund S, Rambech E, Persson A, Petersen A, Nilbert M.

Eur J Neurol. 2015 Apr;22(4):717-24. doi: 10.1111/ene.12647. Epub 2015 Jan 19.

PMID:
25648859
42.

Multidisciplinary team conferences promote treatment according to guidelines in rectal cancer.

Brännström F, Bjerregaard JK, Winbladh A, Nilbert M, Revhaug A, Wagenius G, Mörner M.

Acta Oncol. 2015 Apr;54(4):447-53. doi: 10.3109/0284186X.2014.952387. Epub 2014 Oct 7.

PMID:
25291075
43.

Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes.

Jönsson JM, Johansson I, Dominguez-Valentin M, Kimbung S, Jönsson M, Bonde JH, Kannisto P, Måsbäck A, Malander S, Nilbert M, Hedenfalk I.

PLoS One. 2014 Sep 16;9(9):e107643. doi: 10.1371/journal.pone.0107643. eCollection 2014.

44.

[Alarming increase in skin cancer. Doubled number of cases within 10 years, according to forecasts from southern Sweden].

Stromberg U, Peterson S, Lejding T, Friberg A, Persson B, Nilbert M.

Lakartidningen. 2014 Aug 6-19;111(32-33):1309-10. Swedish. No abstract available.

45.

Functional implications of the p.Cys680Arg mutation in the MLH1 mismatch repair protein.

Dominguez-Valentin M, Drost M, Therkildsen C, Rambech E, Ehrencrona H, Angleys M, Lau Hansen T, de Wind N, Nilbert M, Juel Rasmussen L.

Mol Genet Genomic Med. 2014 Jul;2(4):352-5. doi: 10.1002/mgg3.80. Epub 2014 May 6.

46.

Discovery-based protein expression profiling identifies distinct subgroups and pathways in leiomyosarcomas.

Kirik U, Hansson K, Krogh M, Jönsson M, Nilbert M, James P, Carneiro A.

Mol Cancer Res. 2014 Dec;12(12):1729-39. doi: 10.1158/1541-7786.MCR-14-0072. Epub 2014 Jul 28.

47.

Key roles for MYC, KIT and RET signaling in secondary angiosarcomas.

Styring E, Seinen J, Dominguez-Valentin M, Domanski HA, Jönsson M, von Steyern FV, Hoekstra HJ, Suurmeijer AJ, Nilbert M.

Br J Cancer. 2014 Jul 15;111(2):407-12. doi: 10.1038/bjc.2014.359. Epub 2014 Jul 1.

48.

Heterogenous mismatch-repair status in colorectal cancer.

Joost P, Veurink N, Holck S, Klarskov L, Bojesen A, Harbo M, Baldetorp B, Rambech E, Nilbert M.

Diagn Pathol. 2014 Jun 26;9:126. doi: 10.1186/1746-1596-9-126.

49.

Acta Oncologica and a new generation of scientists in oncology.

Glimelius B, Johansen C, Muren LP, Nilbert M.

Acta Oncol. 2014 Jul;53(7):849-51. doi: 10.3109/0284186X.2014.913102. No abstract available.

PMID:
24954366
50.

Small soft tissue sarcomas do metastasize: identification of high-risk tumors.

Styring E, Hartman L, Nilbert M, Rissler P, Rydholm A, von Steyern FV.

Ann Surg Oncol. 2014 Nov;21(12):4020-5. doi: 10.1245/s10434-014-3806-3. Epub 2014 Jun 6.

PMID:
24903235

Supplemental Content

Loading ...
Support Center